Dunhill Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Dunhill Financial's DGX Position: Q3 2026 in Review
Dunhill Financial increased its Quest Diagnostics (DGX) stake by 6.9% in Q3 2026, buying an estimated $3.47K and bringing the position to 233 shares worth $53.1K. The position accounts for 0.01% of the portfolio, ranked #323.
Dunhill Financial first reported a position in DGX in Q4 2023 and has held it in 12 quarters since. The position peaked at $60.6K in Q3 2024. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Dunhill Financial held 233 shares of Quest Diagnostics worth $53.1K as of Q3 2026.
- Dunhill Financial bought 15 Quest Diagnostics shares in Q3 2026, an estimated $3.47K.
- Quest Diagnostics made up 0.01% of Dunhill Financial's portfolio in Q3 2026, its #323 holding.
- Dunhill Financial first reported a position in Quest Diagnostics in Q4 2023 and has held it in 12 quarters since.
- Dunhill Financial's Quest Diagnostics position peaked at $60.6K in Q3 2024.
- 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.